ATE547118T1 - Rekombinanter koi-herpesvirus (khv) oder cyprinid-herpesvirus 3 (cyhv-3) und impfstoff zur prävention einer von khv/cyhv-3 bei cyprinus carpio carpio oder cyprinus carpio koi verursachten erkrankung - Google Patents
Rekombinanter koi-herpesvirus (khv) oder cyprinid-herpesvirus 3 (cyhv-3) und impfstoff zur prävention einer von khv/cyhv-3 bei cyprinus carpio carpio oder cyprinus carpio koi verursachten erkrankungInfo
- Publication number
- ATE547118T1 ATE547118T1 AT08803235T AT08803235T ATE547118T1 AT E547118 T1 ATE547118 T1 AT E547118T1 AT 08803235 T AT08803235 T AT 08803235T AT 08803235 T AT08803235 T AT 08803235T AT E547118 T1 ATE547118 T1 AT E547118T1
- Authority
- AT
- Austria
- Prior art keywords
- cyhv
- khv
- carpio
- koi
- herpes virus
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
- A61K39/245—Herpetoviridae, e.g. herpes simplex virus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/20—Antivirals for DNA viruses
- A61P31/22—Antivirals for DNA viruses for herpes viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/525—Virus
- A61K2039/5254—Virus avirulent or attenuated
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
- A61K2039/552—Veterinary vaccine
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
- C12N2710/00011—Details
- C12N2710/16011—Herpesviridae
- C12N2710/16034—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
- C12N2710/00011—Details
- C12N2710/16011—Herpesviridae
- C12N2710/16041—Use of virus, viral particle or viral elements as a vector
- C12N2710/16043—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
- C12N2710/00011—Details
- C12N2710/16011—Herpesviridae
- C12N2710/16041—Use of virus, viral particle or viral elements as a vector
- C12N2710/16045—Special targeting system for viral vectors
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
- C12N2710/00011—Details
- C12N2710/16011—Herpesviridae
- C12N2710/16061—Methods of inactivation or attenuation
- C12N2710/16062—Methods of inactivation or attenuation by genetic engineering
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
- C12N2760/00011—Details
- C12N2760/20011—Rhabdoviridae
- C12N2760/20022—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2800/00—Nucleic acids vectors
- C12N2800/20—Pseudochromosomes, minichrosomosomes
- C12N2800/204—Pseudochromosomes, minichrosomosomes of bacterial origin, e.g. BAC
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2800/00—Nucleic acids vectors
- C12N2800/30—Vector systems comprising sequences for excision in presence of a recombinase, e.g. loxP or FRT
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2810/00—Vectors comprising a targeting moiety
- C12N2810/50—Vectors comprising as targeting moiety peptide derived from defined protein
- C12N2810/60—Vectors comprising as targeting moiety peptide derived from defined protein from viruses
- C12N2810/6072—Vectors comprising as targeting moiety peptide derived from defined protein from viruses negative strand RNA viruses
- C12N2810/6081—Vectors comprising as targeting moiety peptide derived from defined protein from viruses negative strand RNA viruses rhabdoviridae, e.g. VSV
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Virology (AREA)
- Immunology (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Microbiology (AREA)
- Organic Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Genetics & Genomics (AREA)
- Epidemiology (AREA)
- Mycology (AREA)
- Biotechnology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Biomedical Technology (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Biochemistry (AREA)
- General Engineering & Computer Science (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Molecular Biology (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP07115093A EP2031065A1 (de) | 2007-08-28 | 2007-08-28 | Rekombinanter Koi-Herpesvirus (KHV) oder Cyprinid-Herpesvirus 3 (CyHV-3) und Impfstoff zur Prävention einer von KHV/CyHV-3 bei Cyprinus carpio carpio oder Cyprinus carpio (Koi) verursachten Erkrankung |
EP07120939 | 2007-11-16 | ||
PCT/EP2008/061168 WO2009027412A1 (en) | 2007-08-28 | 2008-08-26 | A recombinant koi herpesvirus (khv) or cyprinid herpesvirus 3 (cyhv-3) and a vaccine for the prevention of a disease caused by khv/cyhv-3 in cyprinus carpio carpio or cyprinus carpio koi |
Publications (1)
Publication Number | Publication Date |
---|---|
ATE547118T1 true ATE547118T1 (de) | 2012-03-15 |
Family
ID=40020044
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AT08803235T ATE547118T1 (de) | 2007-08-28 | 2008-08-26 | Rekombinanter koi-herpesvirus (khv) oder cyprinid-herpesvirus 3 (cyhv-3) und impfstoff zur prävention einer von khv/cyhv-3 bei cyprinus carpio carpio oder cyprinus carpio koi verursachten erkrankung |
Country Status (12)
Country | Link |
---|---|
US (1) | US20110287050A1 (de) |
EP (1) | EP2195021B1 (de) |
JP (1) | JP2010536394A (de) |
CN (1) | CN101820905A (de) |
AT (1) | ATE547118T1 (de) |
BR (1) | BRPI0816134A2 (de) |
MD (1) | MD20100029A (de) |
MX (1) | MX2010002122A (de) |
RS (1) | RS20100059A (de) |
RU (1) | RU2010111725A (de) |
TW (1) | TW200924792A (de) |
WO (1) | WO2009027412A1 (de) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN112316113A (zh) * | 2018-11-05 | 2021-02-05 | 共鳞实业(深圳)有限公司 | 用于预防或治疗鱼类感染CyHV-2的试剂及应用 |
Families Citing this family (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2010113988A1 (ja) * | 2009-03-31 | 2010-10-07 | 国立大学法人三重大学 | 抗gpcr抗体の製造方法および抗gpcr抗体 |
EP2487241A1 (de) | 2011-02-09 | 2012-08-15 | Westfälische Wilhelms-Universität Münster | RNAi-Agenzien und -Zusammensetzungen, die als Therapeutika für Karpfen von Nutzen sind |
RU2662768C2 (ru) | 2011-12-30 | 2018-07-31 | Гесвал с.а. | Рекомбинантный герпесвирус кои (khv) и вакцина для профилактики заболевания, вызываемого khv |
CN102973951A (zh) * | 2012-11-26 | 2013-03-20 | 吉林农业大学 | 一种锦鲤疱疹病毒orf25核酸疫苗 |
CN104031143A (zh) * | 2013-07-02 | 2014-09-10 | 广东省农业科学院动物卫生研究所 | 一种抗鲤科疱疹病毒3型鸡卵黄抗体及其制备方法和应用 |
RU2732120C2 (ru) * | 2015-02-11 | 2020-09-11 | Альма Матер Студиорум Университа Ди Болонья | Герпесвирус с измененным спектром мишеней, содержащий гибридный гликопротеин н |
CN105755014B (zh) * | 2016-03-23 | 2019-03-19 | 中国科学院水生生物研究所 | CaHV-TNFR特异基因及应用 |
CN106834352B (zh) * | 2017-02-27 | 2020-06-16 | 苏州大学 | 基于杆状病毒表达系统制备包裹鲤疱疹病毒ii型抗原的多角体的方法 |
CN109294974B (zh) * | 2018-10-22 | 2022-09-13 | 浙江省淡水水产研究所 | 一种异育银鲫脊髓组织细胞系及其构建方法与其应用 |
CN110423714B (zh) * | 2019-08-19 | 2020-11-06 | 中国水产科学研究院长江水产研究所 | 一种乳酸菌复合菌剂及其在抗鲤疱疹病毒ii型中的应用 |
CN113068640A (zh) * | 2021-03-19 | 2021-07-06 | 北京市水产科学研究所(国家淡水渔业工程技术研究中心) | 一种红色皮肤高覆盖率锦鲤品系的选育方法 |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0382271B1 (de) | 1989-02-04 | 1994-12-21 | Akzo Nobel N.V. | Tocole als Impfstoffadjuvans |
JPH09267A (ja) * | 1995-06-23 | 1997-01-07 | Kyoritsu Shoji Kk | チミジンキナーゼ遺伝子に変異を有する組換えネコヘルペスウイルス1型及びそれを含むワクチン |
PT1140152E (pt) | 1998-12-21 | 2003-11-28 | Akzo Nobel Nv | Metodo para producao de vacinas inactivadas adjuvadas com uma emulsao a/o |
IL153775A0 (en) * | 2003-01-01 | 2003-07-31 | Yissum Res Dev Co | Immunizing fish against viral infection |
-
2008
- 2008-08-26 MD MDA20100029A patent/MD20100029A/xx not_active Application Discontinuation
- 2008-08-26 WO PCT/EP2008/061168 patent/WO2009027412A1/en active Application Filing
- 2008-08-26 US US12/671,811 patent/US20110287050A1/en not_active Abandoned
- 2008-08-26 RU RU2010111725/10A patent/RU2010111725A/ru not_active Application Discontinuation
- 2008-08-26 BR BRPI0816134-8A patent/BRPI0816134A2/pt not_active IP Right Cessation
- 2008-08-26 CN CN200880104727A patent/CN101820905A/zh active Pending
- 2008-08-26 AT AT08803235T patent/ATE547118T1/de active
- 2008-08-26 JP JP2010522351A patent/JP2010536394A/ja active Pending
- 2008-08-26 RS RSP20100059 patent/RS20100059A/en unknown
- 2008-08-26 EP EP20080803235 patent/EP2195021B1/de not_active Not-in-force
- 2008-08-26 MX MX2010002122A patent/MX2010002122A/es not_active Application Discontinuation
- 2008-08-28 TW TW97132864A patent/TW200924792A/zh unknown
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN112316113A (zh) * | 2018-11-05 | 2021-02-05 | 共鳞实业(深圳)有限公司 | 用于预防或治疗鱼类感染CyHV-2的试剂及应用 |
Also Published As
Publication number | Publication date |
---|---|
TW200924792A (en) | 2009-06-16 |
MD20100029A2 (ro) | 2010-08-31 |
BRPI0816134A2 (pt) | 2015-07-28 |
WO2009027412A1 (en) | 2009-03-05 |
MX2010002122A (es) | 2010-07-06 |
RS20100059A (en) | 2011-06-30 |
JP2010536394A (ja) | 2010-12-02 |
US20110287050A1 (en) | 2011-11-24 |
EP2195021B1 (de) | 2012-02-29 |
RU2010111725A (ru) | 2011-10-10 |
CN101820905A (zh) | 2010-09-01 |
MD20100029A (ro) | 2010-08-31 |
EP2195021A1 (de) | 2010-06-16 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ATE547118T1 (de) | Rekombinanter koi-herpesvirus (khv) oder cyprinid-herpesvirus 3 (cyhv-3) und impfstoff zur prävention einer von khv/cyhv-3 bei cyprinus carpio carpio oder cyprinus carpio koi verursachten erkrankung | |
MX2018014573A (es) | Vacuna contra el virus del zika. | |
MX2020010941A (es) | Moleculas y composiciones novedosas de arn de vsr para vacunacion. | |
HK1120730A1 (en) | Nipah virus vaccines nipah | |
NZ607477A (en) | Non-natural amino acid replication-dependent microorganisms and vaccines | |
AR056566A1 (es) | Vacunas y procedimientos para tratar la gripe canina | |
WO2007002470A3 (en) | Inactivated chimeric vaccines and related methods of use | |
HK1124868A1 (en) | Truncated human papillomavirus type 16 l1 proteins | |
WO2008054540A3 (en) | Inducing immune responses to influenza virus using polypeptide and nucleic acid compositions | |
EA201070794A1 (ru) | Рекомбинантные антигены rsv | |
RU2017116973A (ru) | Способы применения и композиции нейрегулинов для предотвращения, лечения или замедления сердечной недостаточности с сохраненной фракцией выброса | |
PH12014501388A1 (en) | A recombinant koi herpesvirus (khv) and vaccine for the prevention of a disease caused by khv | |
ATE452900T1 (de) | Impfstoff gegen das west-nile-virus | |
CO6361950A2 (es) | Composiciones, vacunas y metodos del virus del herpes del ganado bovino -1 | |
WO2007150008A3 (en) | Polypeptides from african swine virus as vaccines for preventive and therapeutic use | |
AR094725A1 (es) | Parvovirus 5a porcino, métodos de uso y vacuna | |
EP2552490A4 (de) | Ektodomänen des influenza-matrix-2-proteins, expressionssystem dafür und verwendungen davon | |
HK1128622A1 (en) | Use of thymosin | |
AR048671A1 (es) | Procedimiento de vacunacion contra la infeccion testicular por bvdv | |
AR065765A1 (es) | Composicion de vacuna para el tratamiento de enfermedades infecciosas respiratorias | |
MX363264B (es) | Vectores de vacuna recombinante de herpesvirus bovino 1 (bohv-1) con baja virulencia. | |
AR040601A1 (es) | Mutantes ehv negativos de gm sin elementos heterologos | |
EA201591095A1 (ru) | Белок slurp-1 для применения в лечении глазных болезней | |
NZ591738A (en) | Non-typhoidal salmonella vaccines comprising a polypeptide which is an outer membrane protein d of non typoidal salmonella | |
TN2014000393A1 (en) | Modified marek's disease virus, and vaccines made therefrom |